Market Expansion Support

Knowing that the healthcare industry is constantly growing and evolving, we knew that we had to actively engage in our client’s key developments to understand their needs ๐Ÿš€ .

For years we have been helping companies to expand to global markets sharing a deep understanding of stringent regulations ๐Ÿ”’ .ย As a dedicated partner to several companies located outside of the European Union, one of our current activities is assisting our clients to successfully expand into the EU market.

Entering the intricate landscape of the EU market can be complicated, and we can facilitate the transition by offering comprehensive services in regulatory strategy, country selection, and legal framework identification.

Our expert team creates a tailored regulatory strategy while taking into account the specific needs and nuances of each of our clientโ€™s products.
Our great strength lies in the teams of ex-regulatory professionals who can support in ๐ŸŒ global regions including the US, Canada, EU, UK, Switzerland, Russia, CIS, Australia, New Zealand, Balkans, Turkey, and South Africa.

If you require assistance in market expansion into the EU or other global markets, Pharmexon is glad to support you.

Latest Posts
๐Ÿ“š Strengthening Our Expertise: Product-Specific Guidance

At Pharmexon, we believe in fostering a culture of continuous learning to stay ahead in

Regulatory Intelligence September – October 2024

The Pharmaceutical Industry is incredibly dynamic, with constant updates occurring all through various fields encompassing

๐Ÿšจ Important Update from the European Medicines Agency (EMA) ๐Ÿšจ

This fall a significant EMA update of guideline on Environmental Risk Assessment (ERA) for Medicinal

Pharmexon Company Breakfast

Only a couple of weeks ago, one of Pharmexonโ€™s favorite traditions occurredโ€” the Pharmexon Company

๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฒ๐˜…๐—ผ๐—ป ๐—ต๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฝ๐—น๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด BioBridges Conference ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ฎ๐—ด๐˜‚๐—ฒ!

From September 26th to 27th, the event brought together professionals in bioequivalence and pharmaceutical development,